Insulet Corp
Gesloten
SectorGezondheidszorg
137.83 4.57
Overzicht
Wijziging aandelenprijs
24u
Min
131.56
Max
132.88
Inkomsten | 3.9M 95M |
|---|---|
Verkoop | 40M 802M |
K/W Sectorgemiddelde | 27.618 56.597 |
EPS | 1.66 |
Winstmarge | 11.85 |
Werknemers | 5,400 |
EBITDA | -22M 132M |
Volgende Winsten | 5 nov 2026 |
|---|
Marktkapitalisatie | -1.5B 10B |
|---|---|
Vorige openingsprijs | 133.26 |
Vorige sluitingsprijs | 137.83 |
Nieuwssentiment
By Acuity
64%
36%
287 / 339 Rangschikking in Healthcare
Insulet Corp Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Insulet Corp Prognose
Sentiment
By Acuity
287 / 339 Rangschikking in Gezondheidszorg
Nieuwssentiment
Bullish Bewijs
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Boven gemiddelde
Financieel
Verkoop- en administratiekosten
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Insulet Corp
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.